{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:01:00Z","timestamp":1787180460708,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.thromres.2025.109280","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T12:00:39Z","timestamp":1738670439000},"page":"109280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Danaparoid failure in heparin-induced thrombocytopenia due to acquired antithrombin deficiency: A case report"],"prefix":"10.1016","volume":"247","author":[{"given":"C.","family":"Farkh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.H.","family":"Wicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Perrier-Cornet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Koskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ajzenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Faille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2025.109280_bb0005","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.jacc.2016.02.073","article-title":"Heparin-induced thrombocytopenia: a comprehensive clinical review","volume":"67","author":"Salter","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2025.109280_bb0010","article-title":"Diagnostic et prise en charge d\u2019une thrombop\u00e9nie induite par l\u2019h\u00e9parine","author":"Gruel","year":"2019","journal-title":"Propositions du Groupe d\u2019Int\u00e9r\u00eat en H\u00e9mostase P\u00e9riop\u00e9ratoire (GIHP) et du Groupe Fran\u00e7ais d\u2019\u00e9tudes sur l\u2019H\u00e9mostase et la Thrombose (GFHT)."},{"key":"10.1016\/j.thromres.2025.109280_bb0015","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bjh.12059","article-title":"Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition","volume":"159","author":"Watson","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2025.109280_bb0020","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1055\/s-0037-1614536","article-title":"First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet-activation test (HIPA) in comparison with a PF4\/heparin ELISA","volume":"81","author":"Eichler","year":"1999","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109280_bb0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood.V67.1.27.27","article-title":"A diagnostic test for heparin-induced thrombocytopenia","volume":"67","author":"Sheridan","year":"1986","journal-title":"Blood"},{"issue":"95","key":"10.1016\/j.thromres.2025.109280_bb0030","first-page":"967","article-title":"Heparin-induced thrombocytopenia (HIT). A report of 1,478 clinical outcomes of patients treated with danaparoid (Orgaran) from 1982 to mid-2004","author":"Magnani","year":"2006","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109280_bb0035","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00134-009-1464-x","article-title":"Danaparoid cross-reactivity with heparin-induced thrombocytopenia antibodies: report of 12 cases","volume":"35","author":"Tardy-Poncet","year":"2009","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.thromres.2025.109280_bb0040","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ijlh.12221","article-title":"Diagnosis and treatment of disseminated intravascular coagulation","volume":"36","author":"Levi","year":"2014","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.thromres.2025.109280_bb0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1034\/j.1600-0609.2003.00105.x","article-title":"Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failures","volume":"71","author":"Kodityal","year":"2003","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.thromres.2025.109280_bb0050","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1055\/s-0037-1615946","article-title":"A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia","volume":"85","author":"Farner","year":"2001","journal-title":"Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825000295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825000295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:26:18Z","timestamp":1777472778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825000295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":10,"alternative-id":["S0049384825000295"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109280","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Danaparoid failure in heparin-induced thrombocytopenia due to acquired antithrombin deficiency: A case report","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109280"}}